The Yale School of Medicine’s new Center for Infection & Immunity, which launched on Aug. 18, is researching post-acute infection syndromes while encouraging diversity, elevating scientists and incorporating patients as research partners.
The joint team of researchers is looking to use the grant money to revolutionize cancer defense by orchestrating immune responses through mRNA technology.
Quantum-Si, a biotechnology company based in Branford, Connecticut, moved into a new space to support over 100 staff as they continue to develop and market their protein sequencing technology called “Platinum.”